Search by Drug Name or NDC
NDC 59651-0327-01 PHENOXYBENZAMINE HYDROCHLORIDE 10 mg/1 Details
PHENOXYBENZAMINE HYDROCHLORIDE 10 mg/1
PHENOXYBENZAMINE HYDROCHLORIDE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is PHENOXYBENZAMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Phenoxybenzamine is used to treat episodes of high blood pressure and sweating related to pheochromocytoma. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 59651-0327-01Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Phenoxybenzamine
Product Information
| NDC | 59651-0327 |
|---|---|
| Product ID | 59651-327_75f26681-a079-4ff3-9fff-75526041374c |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | PHENOXYBENZAMINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PHENOXYBENZAMINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENOXYBENZAMINE HYDROCHLORIDE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215600 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59651-0327-01 (59651032701)
| NDC Package Code | 59651-327-01 |
|---|---|
| Billing NDC | 59651032701 |
| Package | 100 CAPSULE in 1 BOTTLE (59651-327-01) |
| Marketing Start Date | 2023-05-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |